Related Experiment Video

Updated: Aug 15, 2026

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
15:23

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Published on: May 13, 2010

Additional arrows for the beta-amyloid target

B Cordell1

  • 1California Biotechnology, Inc., Mountain View 94043.

Neurobiology of Aging
|September 1, 1989
PubMed

Insights

Researchers are investigating beta-amyloid production mechanisms to find new Alzheimer's disease therapies. Understanding how beta-amyloid forms is key to identifying effective therapeutic targets.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Alzheimer's disease is characterized by the accumulation of beta-amyloid plaques in the brain.
  • The precise molecular mechanisms driving beta-amyloid genesis remain incompletely understood.
  • Existing molecular tools offer opportunities to experimentally validate proposed pathways.

Purpose of the Study:

  • To elucidate the specific molecular mechanisms underlying beta-amyloid production.
  • To identify and validate novel therapeutic targets for Alzheimer's disease.

Main Methods:

  • Utilizing a range of molecular biology techniques and biochemical assays.
  • Designing experiments to test various postulates of beta-amyloid genesis.
  • Employing advanced imaging and proteomic analyses.

Main Results:

  • Experimental data are currently being generated to differentiate between competing hypotheses.
  • Key molecular players and pathways involved in beta-amyloid formation are being identified.
  • Potential intervention points for modulating beta-amyloid levels are emerging.

Conclusions:

  • Identifying the correct mechanism of beta-amyloid genesis is crucial for developing effective Alzheimer's treatments.
  • This research aims to translate fundamental discoveries into tangible therapeutic strategies.
  • The findings will guide the development of targeted therapies to combat Alzheimer's disease progression.

More Related Videos

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase11:57

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase

Published on: June 24, 2025

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...